Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness

European Journal of Cancer

Volumn 37, Issue 8, 2001, Pages 1041-1052

  Liang, Y ^a   Meleady, P ^a   Cleary, I ^a   McDonnell, S ^a   Connolly, L ^a   Clynes, M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Integrin; Invasion; Matrix metalloproteinase (MMP); Melphalan; Multidrug resistance (MDR); Multidrug resistance protein (MRP); Paclitaxel (Taxol)

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; INTEGRIN; MELPHALAN; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL MOTILITY; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NOSE CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; INTEGRINS; MELPHALAN; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0035038457     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00086-7     Document Type: Article

References (42)

1. Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines
2. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability
3. Metastatic behavior of an adriamycin-resistant murine tumor
4. Characterization of cysteine proteases and their endogenous inhibitors in MCF-7 and adriamycin-resistant MCF-7 human breast cancer cells
5. Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells
6. Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells
7. Metastatic potential and multidrug resistance correlation in the B16 melanoma system
8. Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells
9. Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice
10. Studies of a human tumor cell line with a diploid karyotype
11. Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A
12. A new MDR-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections
13. Antibodies generated to synthetic peptides specifically recognise their target antigens (P-170 and topoisomerase II α) by immunohistochemical techniques and western blotting
14. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance
15. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42
16. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems
17. The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells
18. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
19. IL-1 beta and prostaglandins regulate integrin mRNA expression
20. Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion
21. A rapid in vitro assay for quantitating the invasive potential of tumor cells
22. Identification of a plasma gelatinase in preparations of fibronectin
23. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC 833 and verapamil in human MDR large cell lung cancer cells expressing a 190K membrane protein distinct from P-glycoprotein
24. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells
25. MRP3, an organic anion transporter able to transport anti-cancer drugs
26. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump
27. Acquisition of taxol resistance via P-glycoprotein and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells
28. Degradation of basement membrane by murine tumor cells
29. The ups and downs of alpha2beta1-integrin expression: Contributions to epithelial cell differentiation and the malignant phenotype
30. 1 integrin expression
31. 1 on melanoma cells can inhibit the invasive stage of metastasis formation
32. 1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells
33. Altered expression of integrins in adriamycin-resistant human breast cancer cells
34. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
35. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor- dependent upregulation of matrix metalloproteinase 9 (MMP-9)
36. The alpha3beta1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity
37. Proteolysis and cell migration: Creating a path?
38. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene
39. The human multidrug resistance protein 2 gene: Functional characterization of the 5′-flanking region and expression in hepatic cells
40. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line
41. Transcriptional regulation of cell invasion. AP-1 regulation of a multigenic invasion programme